Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Photoswitchable COX-2-Selective Inhibitors as Light-Regulated Anti-Inflammatory Agents

  • Morales Jiménez, Amanda
  • Cruz, Alejandro
  • Pérez-Sánchez, Álex|||0000-0003-3636-3885
  • D'Avino, Danilo
  • Galassi, Gaia
  • Milano, Erica Ginevra
  • Bernareggi, Irene
  • Arenós-Bach, Carla|||0009-0002-0297-539X
  • Grazioso, Giovanni
  • Alibés, Ramon|||0000-0002-7997-2691
  • Hernando, Jordi|||0000-0002-1126-4138
  • Gorostiza, Pau|||0000-0002-7268-5577
  • Rossi, Antonietta
  • Pistocchi, Anna
  • Matera, Carlo|||0000-0001-6939-3859
  • Busqué, Félix|||0000-0001-7566-4264
  • González Lafont, Àngels|||0000-0003-0729-2483
  • Lluch, José M.|||0000-0002-7536-1869
Despite their extensive use, the therapeutic potential of nonsteroidal anti-inflammatory drugs (NSAIDs) remains significantly constrained by adverse side effects. This limitation primarily arises from insufficient selectivity, as current NSAIDs inhibit not only the inducible cyclooxygenase-2 (COX-2) isoform at sites of inflammation but also constitutive COX-2 in healthy tissues and, frequently, cyclooxygenase-1. To address this challenge, we developed photoswitchable NSAIDs that combine COX-2 selectivity with light-controlled activity to enable spatiotemporal confinement of the therapeutic effect at inflamed tissues. Following computational design and screening of a library of azoaromatic derivatives of celecoxib─the most widely used COX-2 selective NSAID─three photoswitchable analogues were synthesized, which exhibited reversible and efficient trans-cis photoconversion. Light-controlled and selective COX-2 inhibition was demonstrated for these compounds in vitro, reaching up to 5-fold potency enhancement in macrophage assays upon photoisomerization from the initial, dark-adapted trans isomer to the cis state. The best candidate displayed in vivo efficacy in a zebrafish model of acute inflammation, where administration of the photoinduced cis form reduced leukocyte recruitment at the wound site. These findings position photoswitchable NSAIDs as a promising alternative to conventional drugs for treating inflammation and related conditions, including cancer.
Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Brain state identification and neuromodulation to promote recovery of consciousness

  • Van Der Lande, Glenn J. M.
  • Casas-Torremocha, Diana
  • Manasanch, Arnau
  • Dalla Porta, Leonardo
  • Gosseries, Olivia
  • Alnagger, Naji
  • Barra, Alice
  • Mejias, Jorge F.
  • Panda, Rajanikant
  • Riefolo, Fabio
  • Thibaut, Aurore
  • Bonhomme, Vincent
  • Thirion, Bertrand
  • Clasca, Francisco
  • Gorostiza, Pau
  • Sanchez-Vives, Maria V.
  • Deco, Gustavo
  • Laureys, Steven
  • Zamora-López, Gorka
  • Annen, Jitka
Experimental and clinical studies of consciousness identify brain states (i.e. quasi-stable functional cerebral organization) in a non-systematic manner and largely independent of the research into brain state modulation. In this narrative review, we synthesize advances in the identification of brain states associated with consciousness in animal models and physiological (sleep), pharmacological (anaesthesia) and pathological (disorders of consciousness) states of altered consciousness in humans. We show that in reduced consciousness the frequencies in which the brain operates are slowed down and that the pattern of functional communication is sparser, less efficient, and less complex. The results also highlight damaged resting-state networks, in particular the default mode network, decreased connectivity in long-range connections and especially in the thalamocortical loops. Next, we show that therapeutic approaches to treat disorders of consciousness, through pharmacology (e.g. amantadine, zolpidem), and (non-) invasive brain stimulation (e.g. transcranial direct current stimulation, deep brain stimulation) have shown partial effectiveness in promoting consciousness recovery. Although some features of conscious brain states may improve in response to neuromodulation, targeting often remains non-specific and does not always lead to (behavioural) improvements. The fields of brain state identification and neuromodulation of brain states in relation to consciousness are showing fascinating developments that, when integrated, might propel the development of new and better-targeted techniques for disorders of consciousness. We here propose a therapeutic framework for the identification and modulation of brain states to facilitate the interaction between the two fields. We propose that brain states should be identified in a predictive setting, followed by theoretical and empirical testing (i.e. in animal models, under anaesthesia and in patients with a disorder of consciousness) of neuromodulation techniques to promote consciousness in line with such predictions. This framework further helps to identify where challenges and opportunities lay for the maturation of brain state research in the context of states of consciousness. It will become apparent that one angle of opportunity is provided through the addition of computational modelling. Finally, it aids in recognizing possibilities and obstacles for the clinical translation of these diagnostic techniques and neuromodulation treatment options across both the multimodal and multi-species approaches outlined throughout the review., NA is research fellow, OG and AT are Research Associates, and SL is the research director at Fonds de la Recherche Scientifique (FRS-FNRS). JA is a postdoctoral fellow at the Fonds voor Wetenschappelijk Onderzoek (FWO) (1265522N). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the FNRS PDR project (T.0134.21), the ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), the fund Generet, the King Baudouin Foundation, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PROgramme de Développement d'Expériences scientifiques (PRODEX Programme), the Public Utility Foundation `Université Européenne du Travail', `Fondazione Europea di Ricerca Biomedica', the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the DOCMA project (EU-H2020-MSCA-RISE-778234), the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research (FERB Onlus). EU grants ICT-36-2020-101016787 (DEEPER), EIC Pathfinder GAP-101130883 (PHOTOTHERAPORT), and -EIC-2023-PATHFINDEROPEN-101130650 (META-BRAIN), Government of Catalonia AGAUR [Centres de Recerca de Catalunya (CERCA) Programme, 2021-SGR-01410; AGAUR 2021-SGR-01165 - NEUROVIRTUAL], Ministerio de Ciencia e Innovación (MICINN) grants PID2019-111493RB-I00 (DEEP RED) and PID2022- 142609OB-I00 (EPILLUM), PID2020-112947RB-I00 financed by Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 (CORTICOMOD), and Fundaluce and 'la Caixa' foundations (ID 100010434, agreement LCF/PR/HR19/52160010).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Discotic amphiphilic supramolecular polymers for drug release and cell activation with light

  • Santini, Ramona
  • Fuentes, Edgar
  • Maleeva, Galyna
  • Matera, Carlo
  • Riefolo, Fabio
  • Berrocal, José Augusto
  • Albertazzi, Lorenzo
  • Gorostiza, Pau
  • Pujals, Silvia
The limited efficacy shown by drug delivery systems so far prompts the development of new molecular approaches for releasing drugs in a controlled and selective manner. Light is a privileged stimulus for delivery because it can be applied in sharp spatiotemporal patterns and is orthogonal to most biological processes. Supramolecular polymers form molecular nanostructures whose robustness, versatility, and responsivity to different stimuli have generated wide interest in materials chemistry. However, their application as drug delivery vehicles has received little attention. We built supramolecular polymers based on discotic amphiphiles that self-assemble in linear nanostructures in water. They can integrate diverse amphiphilic bioligands and release them upon illumination, acutely producing functional effects under physiological conditions. We devised two strategies for drug incorporation into the photoswitchable nanofibers. In the co-assembly strategy, discotic monomers with and without conjugated bioligands were co-assembled in helicoidal supramolecular fibers. In the drug embedding approach, we integrated a potent agonist of muscarinic receptors into the discotic polymer by noncovalent stacking interactions. This ligand can be released on demand with light ex situ and in situ, rapidly activating the target receptor and triggering intracellular responses. These novel discotic supramolecular polymers can be light-driven drug carriers for small, planar, and amphiphilic drugs., The authors wish to thank Unai Elezcano and Sònia Varon for help with the synthesis and purification. The authors wish to thank Isabel Oliveira and David Izquierdo for the support and useful discussion. This research was funded by the EU Horizon 2020 Framework Programme for Research and Innovation, including the European Innovation Council Pathfinder (Phototheraport, 101130883), the Human Brain Project (WaveScalES, SGA3, 945539), and Information and Communication Technologies (Deeper, ICT-36-2020-101016787); by the Government of Catalonia (CERCA Programme; AGAUR 2021-SGR-01410); by the Spanish Ministry of Science and Innovation (DEEP RED, grant PID2019-111493RB-I00; EPILLUM, grant AEI/10.13039/501100011033; STROMATARGET, grant PID2019-109450RB-I00/AEI/10.13039/501100011033; Research Network in Biomedicine eBrains-Spain, RED2022-134823-E; Ramón y Cajal Investigator grant RYC2021-033056-I financed by MCIN/AEI/10.13039/501100011033 and European Union NextGenerationEU/PRTR to G. M.); and by the Erasmus + Unipharma Graduates Programme to R. S., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Long-Distance Charge Transport between Cytochrome c and Complex III is Mediated by Protons and Reactive Oxygen Species

  • Lagunas, Anna
  • Gomila, Alexandre M J
  • Nin-Hill, Alba
  • Guerra-Castellano, Alejandra
  • Pérez-Mejías, Gonzalo
  • Samitier, Josep
  • Rovira, Carme
  • Rosa, Miguel A. de la
  • Díaz-Moreno, Irene
  • Gorostiza, Pau
Electron transfer (ET) between redox proteins is an essential process in the respiratory and photosynthetic transport chains. While intra-protein ET is well characterized, the experimental methods to investigate inter-protein ET are limited by the presence of the solvent and by the transient nature of the protein-protein interaction and ET event, which are averaged in protein ensembles. Wiring precisely oriented redox protein partners to the nanoscale electrodes of an electrochemical scanning tunneling microscope allows recording the time- and distance-dependence of the current flowing between them. These methods have revealed that the current flowing between individual protein pairs extends beyond tunneling distances and that it is electrochemically gated. However, the corresponding mechanism and the identity of the charge carriers in aqueous solution remain to be elucidated. To determine the species involved in long-distance charge transport between the redox partner proteins Cc and Cc1 of the respiratory chain, recordings are performed as a function of pH, in heavy water solutions, and in degassed solutions. It is observed that the spatial span and electrochemical gating of long-distance currents are reduced at high pH, in heavy water, and at low oxygen concentration, showing that the currents are assisted by superoxide anions and by protons., This research was supported by the Government of Catalonia (CERCA Program; AGAUR 2021-SGR-01410, 2021-SGR-01545, and 2021-SGR-00680); by the Spanish Ministry of Science and Innovation (grants AEI / 10.13039 / 501100011033; PID2021-126663NB-I00 and PID2024-157414NB-I00; Research Network in Biomedicine eBrains-Spain, RED2022-134823-E; PID2020-118893GB-100, CEX2021-001202-M, a postdoctoral fellowship Margarita Salas to A.N.-H., a postdoctoral fellowship POSTD.O.C_21_00395, financed by the Junta de Andalucía /CUII and by the ESF+′ to A.G.-C., and the Complementary Plan of Biotechnology applied to Health coordinated by IBEC within the framework of Recovery, Transformation, and Resiliency Plan (C17.I1) funded by the European Commission NextGenerationEU); by the EU Horizon 2020 Framework Programme for Research and Innovation (including the European Innovation Council Pathfinder (Phototheraport, 101130883), and Information and Communication Technologies (Deeper, ICT-36-2020-101016787)); and by the Networking Biomedical Research Center (CIBER is an initiative funded by the VI National R&D&i Plan 2008-2011, Iniciativa Ingenio 2010, Consolider Program, CIBER Actions and the Instituto de Salud Carlos III, with the support of the European Regional Development Fund ERDF); and by Ramón Areces Foundation (LEUCYTO-FRA2025-MAR)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Brain state identification and neuromodulation to promote recovery of consciousness

  • Van Der Lande, Glenn J. M.
  • Casas-Torremocha, Diana
  • Manasanch, Arnau
  • Dalla Porta, Leonardo
  • Gosseries, Olivia
  • Alnagger, Naji
  • Barra, Alice
  • Mejias, Jorge F.
  • Panda, Rajanikant
  • Riefolo, Fabio
  • Thibaut, Aurore
  • Bonhomme, Vincent
  • Thirion, Bertrand
  • Clasca, Francisco
  • Gorostiza, Pau
  • Sanchez-Vives, Maria V.
  • Deco, Gustavo
  • Laureys, Steven
  • Zamora-López, Gorka
  • Annen, Jitka
Experimental and clinical studies of consciousness identify brain states (i.e. quasi-stable functional cerebral organization) in a non-systematic manner and largely independent of the research into brain state modulation. In this narrative review, we synthesize advances in the identification of brain states associated with consciousness in animal models and physiological (sleep), pharmacological (anaesthesia) and pathological (disorders of consciousness) states of altered consciousness in humans. We show that in reduced consciousness the frequencies in which the brain operates are slowed down and that the pattern of functional communication is sparser, less efficient, and less complex. The results also highlight damaged resting-state networks, in particular the default mode network, decreased connectivity in long-range connections and especially in the thalamocortical loops. Next, we show that therapeutic approaches to treat disorders of consciousness, through pharmacology (e.g. amantadine, zolpidem), and (non-) invasive brain stimulation (e.g. transcranial direct current stimulation, deep brain stimulation) have shown partial effectiveness in promoting consciousness recovery. Although some features of conscious brain states may improve in response to neuromodulation, targeting often remains non-specific and does not always lead to (behavioural) improvements. The fields of brain state identification and neuromodulation of brain states in relation to consciousness are showing fascinating developments that, when integrated, might propel the development of new and better-targeted techniques for disorders of consciousness. We here propose a therapeutic framework for the identification and modulation of brain states to facilitate the interaction between the two fields. We propose that brain states should be identified in a predictive setting, followed by theoretical and empirical testing (i.e. in animal models, under anaesthesia and in patients with a disorder of consciousness) of neuromodulation techniques to promote consciousness in line with such predictions. This framework further helps to identify where challenges and opportunities lay for the maturation of brain state research in the context of states of consciousness. It will become apparent that one angle of opportunity is provided through the addition of computational modelling. Finally, it aids in recognizing possibilities and obstacles for the clinical translation of these diagnostic techniques and neuromodulation treatment options across both the multimodal and multi-species approaches outlined throughout the review., NA is research fellow, OG and AT are Research Associates, and SL is the research director at Fonds de la Recherche Scientifique (FRS-FNRS). JA is a postdoctoral fellow at the Fonds voor Wetenschappelijk Onderzoek (FWO) (1265522N). The study was further supported by the University and University Hospital of Liège, the BIAL Foundation, the Belgian National Funds for Scientific Research (FRS-FNRS), the European Union's Horizon 2020 Framework Programme for Research and Innovation under Specific Grant Agreement No. 945539 (Human Brain Project SGA3), the FNRS PDR project (T.0134.21), the ERA-Net FLAG-ERA JTC2021 project ModelDXConsciousness (Human Brain Project Partnering Project), the fund Generet, the King Baudouin Foundation, the Télévie Foundation, the European Space Agency (ESA) and the Belgian Federal Science Policy Office (BELSPO) in the framework of the PROgramme de Développement d'Expériences scientifiques (PRODEX Programme), the Public Utility Foundation `Université Européenne du Travail', `Fondazione Europea di Ricerca Biomedica', the BIAL Foundation, the Mind Science Foundation, the European Commission, the Fondation Leon Fredericq, the Mind-Care foundation, the DOCMA project (EU-H2020-MSCA-RISE-778234), the National Natural Science Foundation of China (Joint Research Project 81471100) and the European Foundation of Biomedical Research (FERB Onlus). EU grants ICT-36-2020-101016787 (DEEPER), EIC Pathfinder GAP-101130883 (PHOTOTHERAPORT), and -EIC-2023-PATHFINDEROPEN-101130650 (META-BRAIN), Government of Catalonia AGAUR [Centres de Recerca de Catalunya (CERCA) Programme, 2021-SGR-01410; AGAUR 2021-SGR-01165 - NEUROVIRTUAL], Ministerio de Ciencia e Innovación (MICINN) grants PID2019-111493RB-I00 (DEEP RED) and PID2022- 142609OB-I00 (EPILLUM), PID2020-112947RB-I00 financed by Ministerio de Ciencia e Innovación (MCIN)/Agencia Estatal de Investigación (AEI)/10.13039/501100011033 (CORTICOMOD), and Fundaluce and 'la Caixa' foundations (ID 100010434, agreement LCF/PR/HR19/52160010).